A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group
about
Management of bleeding and coagulopathy following major trauma: an updated European guideline.Age of red blood cells and transfusion in critically ill patientsEffect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulationGuidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaComparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disordersComparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disordersTransfusion of fresher versus older red blood cells for all conditionsRestrictive versus liberal red blood cell transfusion strategies for patients with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell supportTransfusion thresholds and other strategies for guiding allogeneic red blood cell transfusionFibrinogen concentrate in bleeding patientsRed cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseRed cell transfusion management for patients undergoing cardiac surgery for congenital heart diseasePlasma transfusion strategies for critically ill patientsPlasma transfusion strategies for critically ill patientsTransfusion of fresher versus older red blood cells for all conditionsTransfusion thresholds and other strategies for guiding allogeneic red blood cell transfusionLow versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infantsAnti-fibrinolytic use for minimising perioperative allogeneic blood transfusionThrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusionCell salvage for minimising perioperative allogeneic blood transfusionAnti-fibrinolytic use for minimising perioperative allogeneic blood transfusionDesmopressin for minimising perioperative allogeneic blood transfusionSurviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?Clinical evidence of blood transfusion effectivenessAnemia of chronic disease: a harmful disorder or an adaptive, beneficial response?Non-variceal upper gastrointestinal haemorrhage: guidelinesRecently published papers: of head injuries, high frequencies and haemodynamic optimizationVariation in red cell transfusion practice in the intensive care unit: a multicentre cohort studyRecently published papers: a number of treatment controversiesErythropoietin mimics the acute phase response in critical illnessVariation in sepsis care: a wake-up callBlood substitutesDebate: transfusing to normal haemoglobin levels will not improve outcomeDebate: Transfusing to normal hemoglobin levels improves outcome.Paper reports overview: Restrictive transfusions, experienced radiologists and prone positioningICU Cornerstone: changing our view of blood transfusionsProtocol-driven care in the intensive care unit: a tool for quality.22nd International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 19-22 March 2002Clinical review: hemorrhagic shock
P2860
Q21092902-03C2E286-ED70-4875-9109-7047E469E536Q21195745-10446B49-A3CB-4B9B-9545-8B7ACD9F6B61Q21254582-9D11EADA-E17E-4EC8-A5D3-F40F7BC0A78BQ22241905-C47144C9-9FBE-4372-96B2-969B508123D5Q24186615-610CA34E-97AE-476D-9B21-3CA4964F3107Q24187692-4881CD87-7F6F-4640-83BD-253D7E20B51FQ24187965-7A44D08A-31F0-4278-BFA2-226B7F6D66A9Q24193943-4D831A35-AC07-49A9-B11D-F7E507522019Q24200170-B2258CD1-B287-4239-85DA-E96E777216FBQ24200171-D48C5F64-F17C-4BAC-BEB4-19018E774627Q24200508-91390AA9-77BF-44F2-8BDA-1381AC844CC8Q24201453-BDF68082-018A-4286-9DF1-15DDE397DE29Q24201589-796C0CC8-4180-43C1-A619-7236879E2E80Q24201609-6C19C1C4-355E-4C64-B776-3310E0C26274Q24202787-27AB70F2-AAEF-4F99-89D4-B582DCCAEA7DQ24234502-48BDAE7F-07DA-4933-A34A-92C0685C5323Q24235360-D199394E-5D7C-477C-A346-3A7E72BBED85Q24235627-24B92F44-713B-4491-A148-17B71CED1CFBQ24235742-A9820CAF-BCBE-46F6-97E0-4CC72EA257A4Q24235950-26E72612-3722-44E4-8093-4027BECB9447Q24243521-13B3BEAC-F3C6-487E-A30D-F3208A2A17B9Q24247402-DD6712F7-B748-4331-9D41-7AACEA71A6D4Q24644984-547BCB3C-110E-40C4-871E-BB405A741BD2Q24650519-30DDF1F1-B8D2-4254-B0D8-4BF7C076D1E8Q24650921-79A5A833-A4E6-416C-9E84-B611C92A3FD9Q24651385-50D62BE8-2711-425A-A1BE-459AC033CF33Q24685894-C4684BBE-16AF-4C51-9493-826D39646736Q24791109-A5542465-BFE6-468E-98DB-E14BD66D3C94Q24794021-1A7AE219-4CDE-4A45-B33A-CA2578B85566Q24794906-616F2DA2-DEB2-42BB-8178-472FEDE029EAQ24795066-BA1450A6-D3D0-4193-A106-712D1D2403D1Q24795179-77100165-499D-47E7-83DF-0F6C11ECBB14Q24795307-FD4D4A9A-9C61-4B66-89E5-8DDDB9283FC4Q24795926-B594033E-B821-4F4E-A359-D95C3D64C7C4Q24795957-DD0C2A73-0B22-4DDD-A8B2-DAEEFB7BE7A4Q24796357-1F4C8D18-FCCE-4E2D-9B49-6290654DD21AQ24796856-E14FC14D-B1CF-4A72-9E06-4DFA7309EFA7Q24797472-6588B569-715D-40C1-B7B0-AB61D3C75428Q24798640-6BE91212-87CF-419C-9C37-BB9D44E31606Q24799554-1D525DF9-C038-4E3A-A163-8BF9D47E91F8
P2860
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A multicenter, randomized, con ...... ian Critical Care Trials Group
@ast
A multicenter, randomized, con ...... ian Critical Care Trials Group
@en
type
label
A multicenter, randomized, con ...... ian Critical Care Trials Group
@ast
A multicenter, randomized, con ...... ian Critical Care Trials Group
@en
prefLabel
A multicenter, randomized, con ...... ian Critical Care Trials Group
@ast
A multicenter, randomized, con ...... ian Critical Care Trials Group
@en
P2093
P3181
P1476
A multicenter, randomized, con ...... ian Critical Care Trials Group
@en
P2093
Blajchman MA
Marshall J
Pagliarello G
Schweitzer I
Tweeddale M
P304
P3181
P356
10.1056/NEJM199902113400601
P407
P577
1999-02-11T00:00:00Z